Epstein Secrets

ingtontimes.corn/news/2020/sep/2/trump-orders-anarchist- jurisdictions-funding-slash/> (9/2, Dinan, Boyer, 492K) says Trump directed Attorney General Barr "to come up with a list of communities that have forbidden police to step in to stop violence, have declared no-go zones for officers, or pursued `

h/> (9/2, Dinan, Boyer, 492K) says Trump directed Attorney General Barr "to come up with a list of communities that have

escent Plasma. In an op-ed for the New York Times <https://www.nytimes.corn/2020/09/02/opinion/coronavirus-convalescent-plasma.html> (9/2, 18.61M), Daniela J. Lamas, a critical care doctor, questions the Food and Drug Administration's "emergency use authorization for convalescent plasma despite inadequate eviden

e memo "twice mentions New York Mayor Bill de Blasio by name." The Washington Times (9/2, Dinan, Boyer, 492K) says Trump directed Attorney General Barr "to come up with a list of communities that have forbidden police to step in to stop violence, have declared no-go zones for officers, or pursued 'D

ports that in an interview with CNNVi Wednesday, Attorney General Barr "sidestepped questions...about President Trump's

initive answer." Lamas: Insufficient Clinical Data For Efficacy Or Safety Of Convalescent Plasma. In an op-ed for the New York Times (9/2, 18.61M), Daniela J. Lamas, a critical care doctor, questions the Food and Drug Administration's "emergency use authorization for convalescent plasma despite inadequate evide

entions New York Mayor Bill de Blasio by name." EFTA01658690 The Washington Times (9/2, Dinan, Boyer, 492K) says Trump directed Attorney General Barr "to come up with a list of communities that have forbidden police to step in to stop violence, have declared no-go zones for officers, or pursued 'D

ports that in an interview with CNNVi Wednesday, Attorney General Barr "sidestepped questions...about President Trump's

initive answer." Lamas: Insufficient Clinical Data For Efficacy Or Safety Of Convalescent Plasma. In an op-ed for the New York Times (9/2, 18.61M), Daniela J. Lamas, a critical care doctor, questions the Food and Drug Administration's "emergency use authorization for convalescent plasma despite inadequate evide